Inhibikase Therapeutics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

FY: Dec 31 2022

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Mar 31 2022

Regulation FD Disclosure

Changes in Registrant's Certifying Accountant

Results of Operations and Financial Condition

Unregistered Sales of Equity Securities

Regulation FD Disclosure

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Other Events

Entry into a Material Definitive Agreement

Other Events

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Registration statement under Securities Act of 1933

Notice of Effectiveness

Prospectus Supplement for Primary Offering

Registration statement under Securities Act of 1933 (amendment)

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration (IPO) statement under Securities Act of 1933

06b

Prospectus Supplement for Primary Offering

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Required Information in Proxy Statement

Additional Information for Proxy Statement/ Votes

PERCEPTIVE ADVISORS LLC

Nantahala Capital Management, LLC

Sands Capital Life Sciences Pulse Fund II, L.P.

RA CAPITAL MANAGEMENT, L.P.

BERMAN DENNIS N

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; Kolchinsky Peter; Shah Rajeev M.

BlackRock, Inc.

RA CAPITAL MANAGEMENT, L.P.

RA Capital Healthcare Fund LP; RA CAPITAL MANAGEMENT, L.P.; Kolchinsky Peter; Shah Rajeev M.

Munshi Amit

Bellini Roberto

BERMAN DENNIS N

Canner David

Kush Arvind

Aurentz Vincent

PERCEPTIVE ADVISORS LLC

Trails Edge Capital Partners, LP

Commodore Capital LP

ADAR1 Capital Management, LLC

Munshi Amit

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Draft registration statement (confidential submission)

Correspondence with the SEC